The Opioid Abuse and Overdose Epidemic in Ohio: Implications for Pharmacists is organized by Alaska Pharmacists Association (AKPhA). This Conference has been approved for a maximum of 1.5 CPE hours.
Release Date: 4/15/17
Expiration Date: 4/15/20
Drug overdose deaths, especially those attributed to opiates such as prescription analgesics and heroin, continue to be a health care problem of epidemic proportions both nationally and at the state level.
Despite increased efforts by lawmakers, educational efforts, and prescription monitoring systems, such as OARRS, having successfully limited the quantity of unused prescription analgesics in community circulation, many who are addicted to prescription opioids may ultimately turn to heroin due to its ease of accessibility and relatively lower cost. The lacing of heroin with clandestinely-manufactured opioid agents such as fentanyl and carfentanil has further complicated the overdose epidemic.
Effectively treating opioid dependence and increasing accessibility to naloxone as a means to reverse acute opioid overdose may be life-saving, but opponents point out that it may exacerbate the occurrence of opioid overdose deaths. As some of the most trusted and accessible health care professionals in the nation, pharmacists should be prepared to identify patients at risk of opioid overdose and effectively counsel patients and caregivers receiving agents indicated in the treatment of both non-emergent opioid dependence and emergent opioid reversal.
At the completion of this activity, the participant will be able to:
• recognize the severity of the opioid overdose epidemic at both a national and state level;
• describe properties of synthetic compounds likely contributing to the opioid overdose epidemic;
• recognize typical risk factors and clinical presentation of opioid overdose;
• demonstrate an understanding of the pharmacist’s role in opioid overdose prevention;
• demonstrate an understanding of the pharmacist’s role in medication therapy management and counseling regarding pharmacologic maintenance therapy for opioid dependence and emergency opioid overdose; and
• identify limitations of nonprescription naloxone.
Additional details will be posted as soon as information is available.
Emergency Medicine, Psychiatry